ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Regeneron Pharmaceuticals, INC.

Official 2024 U.S. DOL Form 5500 summary for Regeneron Pharmaceuticals, INC. (Regeneron Pharmaceuticals, INC. 401(k) Savings Plan · EIN 13-3444607 · PN 001): $2.61B net assets, 11,960 active participants, and $2.25 per $10,000 (2.25 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorRegeneron Pharmaceuticals, INC.
Filing IdentifierRegeneron Pharmaceuticals, INC. 401(k) Savings Plan · EIN 13-3444607 · PN 001
Plan Category & State401(k) Defined Contribution (NY)
Asset-Size Peer Cohort>$1B
Plan Net Assets (2024)$2.61B
Active Participants11,960
Direct Admin Fee Rate$2.25 per $10,000 (2.25 bps)
Cohort Peer Median$4.40 per $10,000 (4.40 bps)
Primary Recordkeeper / ProviderFidelity Investments
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI

Cross-Agency Entity Graph

Related Filings Across Meru Platforms

Verified federal filings reconciled for Regeneron Pharmaceuticals across sibling Meru AI platforms.